(Q43577835)
Statements
1 reference
IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy (English)
1 reference
Shai Yarkoni
1 reference
Tatyana B Prigozhina
1 reference
Shimon Slavin
1 reference
Nadir Askenasy
1 reference
3 January 2012
1 reference
1 reference
18
1 reference
4
1 reference
523-535
1 reference
Identifiers
1 reference
1 reference